• Angiotensin II Drives NPC Radioresistance via HIF-1α

  2026-08-24

  This study identifies a local angiotensin II–AGT–HIF-1α–HILPDA circuit that suppresses radiation-induced ferroptosis and promotes radioresistance in nasopharyngeal carcinoma. Its results support combining angiotensin II receptor blockade with ferroptosis induction, while providing biomarkers and experimental models for studying heterogeneous radiotherapy response.

• EDC.HCl: Practical Coupling Workflow Guide

  2026-08-24

  EDC.HCl is a water-soluble carbodiimide used to activate carboxyl groups for amide bond formation with primary amines in peptide, bioconjugation, and related in vitro workflows. This guide covers dossier-supported handling and QC boundaries; no in vivo or clinical use is supported by the available information.

• TMRE Mitochondrial Membrane Potential Assay Kit Guide

  2026-08-23

  Turn ΔΨm changes into a practical readout for apoptosis, mitochondrial stress, and sodium-driven necrosis. This guide shows how to use the K2233 kit in live-cell, purified-mitochondria, and high-throughput workflows while avoiding common TMRE staining artifacts.

• Nutlin-3a: A Translational Lens on MDM2

  2026-08-22

  Nutlin-3a is more than a p53 pathway probe: it is a strategic tool for connecting MDM2 biology with cell fate, ferroptosis, and tumor migration questions. This thought-leadership guide translates mechanistic evidence into practical study design for cancer researchers.

• AR Heterogeneity and Castration Response in Prostate Cancer

  2026-08-22

  Li and colleagues show that androgen receptor heterogeneity is functionally relevant in castration-resistant prostate cancer rather than merely a descriptive feature. By combining patient tissue profiling, xenografts, genome-edited LNCaP clones, RNA sequencing, and combination treatment studies, the work connects AR status with distinct enzalutamide responses and identifies BCL-2 as a candidate vulnerability.

• Vincristine Sulfate Workflows for Cancer Research

  2026-08-21

  Build more reproducible vincristine assays with practical guidance on stock preparation, dose selection, orthogonal readouts, and recovery studies. The workflow distinguishes biochemical potency from cell-based response and translates evidence-synthesis principles into better cancer research decisions.

• WNT5a/GSK3/β-Catenin Control of FAP Adipogenesis

  2026-08-20

  The 2020 Cell Death & Differentiation study identifies the WNT5a/GSK3/β-catenin axis as a major regulator of adipogenic drift in skeletal muscle fibro/adipogenic progenitors. By integrating pharmacological inhibition, mass cytometry, network modeling, and transcriptomic datasets, the authors show that GSK3 blockade suppresses FAP adipogenesis, limits muscle fatty degeneration, and enhances pro-myogenic support through follistatin secretion.

• Protease and Phosphatase Inhibitor Cocktail Guide

  2026-08-20

  This EDTA-free cocktail is intended to limit proteolysis and dephosphorylation during biological sample extraction, helping preserve total protein and phosphorylation-sensitive readouts. It is suitable for lysate workflows across mammalian, animal, plant, yeast, and bacterial samples, but should not be added to live cultures or activity assays without separate compatibility testing.

• Quercetin, Hippo Signaling, and Cataract Protection

  2026-08-19

  This 2025 study links quercetin-mediated protection of cataractous lenses to suppression of Hippo pathway signaling, improved redox balance, and preservation of lens epithelial-cell viability. Its combined network-pharmacology, mouse, and oxidative-injury cell models provide a useful mechanistic framework, while also leaving important questions about pathway specificity and clinical transferability.

• T0070907: Selective PPARγ Antagonist

  2026-08-19

  T0070907 is a covalent, selective PPARγ antagonist with a reported IC50 of 1 nM and Ki of 1 nM. It blocks agonist-driven PPARγ transcription, inhibits adipogenesis, and provides a mechanistic probe for PPARγ/RXRα heterodimer modulation and selected cancer cell-cycle studies.

• Arachidonic Acid and Rapid Humoral Immunity

  2026-08-18

  A 2025 study reports that dietary arachidonic acid enhanced rabies vaccine-induced neutralizing antibodies and protection in mice, while oral supplementation accelerated protective antibody development in human volunteers. Its mechanistic contribution is the identification of a lymph-node ARA–PGI2–cAMP/PKA pathway that links dietary lipid metabolism with CD86 expression and B-cell activation-induced cytidine deaminase.

• Intranasal mRNA-LNPs for Direct Brain Delivery

  2026-08-18

  The reference study develops an intranasal brain-targeting lipid nanoparticle platform that uses surface-charge optimization to deliver mRNA through olfactory and trigeminal pathways, avoiding dependence on blood–brain barrier disruption. In a repetitive mild traumatic brain injury mouse model, co-delivery of BDNF and IL-10 mRNAs reduced neuroinflammation, limited neuronal loss, and improved cognition, while highlighting important translational questions about formulation safety, dosing, and human nasal anatomy.

• Angiotensin I/II (1-5): Protocol Guide

  2026-08-17

  This guide explains how to use Angiotensin I/II (1-5), a defined Asp-Arg-Val-Tyr-Ile peptide fragment, in renin-angiotensin system research involving cardiovascular, renal, blood pressure, or aldosterone-related endpoints. It is not intended for unrelated signaling studies, and its insolubility in water requires deliberate solvent selection and vehicle controls.

• Trolox Workflows for Redox-Controlled Organoids

  2026-08-17

  Trolox provides a practical redox-control layer for organoid culture, oxidative injury research, and antioxidant assay benchmarking. This guide combines solvent-aware dosing, organoid-compatible workflow design, and troubleshooting strategies to distinguish genuine cytoprotection from assay artifacts.

• Bafilomycin C1: Designing Smarter Flux Assays

  2026-08-16

  Bafilomycin C1 is a vacuolar H+-ATPases inhibitor that can turn lysosomal acidification into a measurable experimental variable. This guide connects V-ATPase biology with high-content phenotyping, autophagy assay design, and the deep-learning strategy used in iPSC-cardiomyocyte screening.

8505 records 1/567 page Next 12345 下5页 Last page